Age and tumour presentations differ between HPV type 16 positive and other high‐risk HPV type‐positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000–2022

Documenti analoghi

• Spatial evidence for carcinoma in situ ( CIS ) as an entity in human papillomavirus ( HPV )‐associated tonsillar squamous cell carcinoma ( TSCC )
  di: Tobias Näsman, et al.
  Pubblicazione: (2025)
• Therapeutic options for human papillomavirus‐positive tonsil and base of tongue cancer
  di: Mark Zupancic, et al.
  Pubblicazione: (2025)
• Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV‐positive oropharyngeal squamous cell carcinoma
  di: Shengming Xu, et al.
  Pubblicazione: (2024)
• Prevalence and distribution of HPV types in Australian patients with oropharyngeal cancer over time
  di: Lachlan Yaksich, et al.
  Pubblicazione: (2026)
• Outcomes for potentially Resectable patients undergoing primary chemoradiation treatment for T1–T2 HPV Negative oropharyngeal squamous cell carcinoma
  di: Francisco Laxague, et al.
  Pubblicazione: (2024)